| The reverse design moves the centre of rotation medially and downward so the deltoid can elevate the arm without a rotator cuff; a working deltoid and axillary nerve are prerequisites | Boileau et al., J Shoulder Elbow Surg 2005 (PMID 15726075); Hurley et al., rotator cuff consensus 2026 (PMID 42742935) |
| Immediate passive and active motion gave the same outcomes and complications as six weeks without motion (RCT, 86 shoulders) | Hagen et al., J Shoulder Elbow Surg 2020 (PMID 31924519) |
| Early active movement after reverse replacement was safe, with better flexion at three months (Australian RCT, 63 shoulders) | Edwards et al., Shoulder Elbow 2021 (PMID 34659491) |
| A three-week sling gave the same pain and function as no sling, with no complications (RCT, 64 patients) | Torrens et al., J Shoulder Elbow Surg 2025 (PMID 40089015) |
| Dislocation 1.4% with early and with delayed mobilisation across 1,606 shoulders | Alkhouri et al., systematic review 2026 (PMID 42267914) |
| Published protocols immobilise for a mean of 4.7 weeks, start passive motion in week 1, assisted motion at about 4 weeks and active motion at about 6 weeks; all include early deltoid isometrics | Obana et al., 2026 (PMID 42774556); Bullock et al., Int J Sports Phys Ther 2019 (PMID 31021690) |
| The at-risk position (arm extended, adducted and internally rotated) and the twelve-week precaution period are standard teaching, not a trial finding | Boudreau et al., J Orthop Sports Phys Ther 2007; the abstract carries no figures. Practice protocol, Dr Broadhead |
| Dislocation 1.6% after primary reverse replacement, median 7 weeks after surgery, higher after revision and without subscapularis repair (6,621 shoulders) | Lohre et al., ASES Complications of RSA Research Group, J Shoulder Elbow Surg 2024 (PMID 37379964) |
| Most improvement by 6 months, with further gains to 2 years | Simovitch et al., J Bone Joint Surg Am 2017 (PMID 29088034) |
| External rotation on average unchanged after reverse replacement; no deterioration in function between 5 and 20 years in pooled data | Ernstbrunner et al., systematic review 2019 (PMID 30674426) |
| Satisfaction 78% to 88%; at ten years 94% would have the operation again, implant survival 81% at 10 years in that series | Smith et al., J Shoulder Elbow Surg 2024 (PMID 38719073); Sheth et al., J Shoulder Elbow Surg 2022 (PMID 34656776) |
| Driving performance back to pre-operative level at 6 weeks after shoulder arthroplasty on a simulator; no excess crashes in a cohort of 406 | Hasan et al., J Bone Joint Surg Am 2016 (PMID 27605691); DeBernardis et al., 2023 (PMID 36528223) |
| Return to sport 79% to 85% at a mean of 3.4 months; surgeons allow golf and swimming with experience after reverse replacement and advise against weightlifting | Davey et al., J Shoulder Elbow Surg 2021 (PMID 32858195); Singh et al., 2026 (PMID 40538058); Magnussen et al., 2011 (PMID 21051242); Golant et al., 2012 (PMID 21393018) |
| Return to work 64% at a mean of 2.3 months, lower for heavy work | Steinhaus et al., J Shoulder Elbow Surg 2019 (PMID 30885548) |
| Acromial and scapular spine stress fractures 3.8% (6,320 patients) and 2% pooled; 70% atraumatic; mean 11.3 months to diagnosis; osteoporosis and inflammatory arthritis double the risk | Moverman et al., J Bone Joint Surg Am 2024 (PMID 40305832); Elmenawi et al., 2026 (PMID 41602508); Abukar et al., 2026 (PMID 42774521) |
| Nerve injury 1.3% after reverse replacement, axillary nerve 0.6%; neurapraxias recover | North et al., J Shoulder Elbow Surg 2023 (PMID 36427756); LiBrizzi et al., 2019 (PMID 30984892) |
| Ten-year revision for infection 3.1% after reverse replacement in the Nordic registry; Cutibacterium acnes the commonest organism | Moeini et al., Bone Joint J 2019 (PMID 31154848); Nelson et al., J Shoulder Elbow Surg 2016 (PMID 27012542) |
| Symptomatic venous thromboembolism 0.81% after shoulder arthroplasty (12,566 shoulders); routine pharmacological prophylaxis not supported | Na et al., Int Orthop 2022 (PMID 35761099) |
| Sleep improves markedly by six months; 13% to 16% still troubled | Hali et al., Shoulder Elbow 2026 (PMID 42186454) |
| Reverse replacement is 80.9% of primary total shoulder replacements in Australia (2004 to 2022); 12-year cumulative revision 6.8% for osteoarthritis | Ingoe et al., JSES Int 2025 (PMID 40486774); Sandow et al., J Shoulder Elbow Surg 2022 (PMID 35577242), AOANJRR data |
| Home-based rehabilitation matches supervised physiotherapy after shoulder arthroplasty (three RCTs) | Rees et al., JSES Int 2025 (PMID 40959011); SHORT trial, Garrigues et al., 2026; Schick et al., 2023 |
| A six-week home deltoid programme started a year after surgery still improved function | Wittmann et al., RCT 2026 (PMID 40849058) |
| Cryotherapy after shoulder surgery: a trend to less pain, inconsistent across trials; a cold-compression device was no better than ice | Karam et al., Orthop J Sports Med 2025 (PMID 40160286); Noyes and Denard, Am J Orthop 2018 (PMID 29979799) |
| Antibiotic prophylaxis before dental procedures is not routinely recommended in Australia; about 80% of joint replacements trigger a walk-through metal detector | Daly, Aust Prescr 2017; AAOS/AAHKS CPG 2024; Murgier et al., J Exp Orthop 2025 (PMID 41323538) |